Back to search

Article

Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Technology

2021-04-12

Abstract excerpt

<title>Abstract</title> <p>Background: Coronavirus disease 2019 (COVID-19) is an emerging and rapidly evolving disease with no effective drug treatment. Traditional Chinese medicines have been widely used to treat COVID-19 in China. Chansu and its major active constituent, bufalin, exert broad-spectrum antiviral effects. Although the clinical efficacy of Chansu injection for COVID-19 treatment has been confirmed,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e9cfdb24-b16f-5604-a323-e966ebc0add5
DOI
10.21203/rs.3.rs-364843/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Material Basis and Mechanism of Chansu Injection for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking TechnologyDOI 10.21203/rs.3.rs-364843/v2
Select a neighboring publication to make it the new centre.